IN2014KN01411A - - Google Patents

Info

Publication number
IN2014KN01411A
IN2014KN01411A IN1411KON2014A IN2014KN01411A IN 2014KN01411 A IN2014KN01411 A IN 2014KN01411A IN 1411KON2014 A IN1411KON2014 A IN 1411KON2014A IN 2014KN01411 A IN2014KN01411 A IN 2014KN01411A
Authority
IN
India
Prior art keywords
treatment
vitiligo
fluoxetine
disclosed
application
Prior art date
Application number
Inventor
Jing Shang
Sha Liao
Yu Jin
Xiaoli Tian
Guorui Zhao
Jia Zhou
Qian Wang
Silin Chong
Original Assignee
Univ China Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ China Pharma filed Critical Univ China Pharma
Publication of IN2014KN01411A publication Critical patent/IN2014KN01411A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Disclosed is an application of fluoxetine to treatment of depigmentation diseases and particularly to treatment of vitiligo and white hair.
IN1411KON2014 2011-12-07 2012-12-05 IN2014KN01411A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2011104031734A CN102429894B (en) 2011-12-07 2011-12-07 Application of fluoxetine in treatment of depigmentation disease
PCT/CN2012/085929 WO2013083040A1 (en) 2011-12-07 2012-12-05 Application of fluoxetine to treatment of depigmentation diseases

Publications (1)

Publication Number Publication Date
IN2014KN01411A true IN2014KN01411A (en) 2015-10-23

Family

ID=45978483

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1411KON2014 IN2014KN01411A (en) 2011-12-07 2012-12-05

Country Status (7)

Country Link
US (1) US20150065580A1 (en)
EP (1) EP2789333B1 (en)
JP (1) JP2015500249A (en)
CN (1) CN102429894B (en)
CA (1) CA2877423C (en)
IN (1) IN2014KN01411A (en)
WO (1) WO2013083040A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102429894B (en) * 2011-12-07 2013-03-13 中国药科大学 Application of fluoxetine in treatment of depigmentation disease
CN106667903A (en) * 2017-01-05 2017-05-17 山东润泽制药有限公司 Fluoxetine tincture for treating leucoderma
CN108969512A (en) * 2017-06-05 2018-12-11 南京睿鹰润泽生物医药科技有限公司 A kind of medical composition and its use of Fluoxetine or racemic fluoxetine salt form
CN107375428A (en) * 2017-07-20 2017-11-24 山东润泽制药有限公司 A kind of ointment of Prozac combination traditional Chinese medicine ingredients treatment leucoderma and preparation method thereof
CN112007039B (en) * 2019-05-28 2022-05-27 南京睿鹰润泽生物医药科技有限公司 A pharmaceutical composition containing fluoxetine and vitamin D3Or derivatives thereof, and uses thereof
AU2021288166A1 (en) * 2020-06-10 2023-01-19 Ractigen Therapeutics Nucleic acid molecule targeting MITF gene and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10216500A1 (en) * 2002-04-11 2003-10-23 Beiersdorf Ag Hair care products
ITTO20060918A1 (en) * 2006-12-22 2008-06-23 Chiara Cesano COSMETIC AND PHARMACEUTICAL COMPOSITION AND MEANS OF CULTURE FOR THE REGENERATION OF CUTANEOUS FABRIC, AND RELATED USES
WO2008078353A1 (en) * 2006-12-22 2008-07-03 Medestea Internazionale S.P.A. A novel use of antidepressant compounds and related compositions
CN102429894B (en) * 2011-12-07 2013-03-13 中国药科大学 Application of fluoxetine in treatment of depigmentation disease

Also Published As

Publication number Publication date
EP2789333A1 (en) 2014-10-15
CN102429894A (en) 2012-05-02
WO2013083040A1 (en) 2013-06-13
CA2877423C (en) 2018-05-01
EP2789333A4 (en) 2015-06-03
JP2015500249A (en) 2015-01-05
US20150065580A1 (en) 2015-03-05
CA2877423A1 (en) 2013-06-13
EP2789333B1 (en) 2019-05-15
CN102429894B (en) 2013-03-13

Similar Documents

Publication Publication Date Title
HRP20180972T1 (en) Combination of phenoxybenzamine and polymixine e to treat microbial infections
IN2014KN01411A (en)
EP2739357A4 (en) Systems and methods for improving an outside appearance of skin using ultrasound as an energy source
AU341527S (en) Shower head
HK1199828A1 (en) Compositions and methods for stimulating magp-1 to improve the appearance of skin magp-1
HK1201183A1 (en) Combination of plant extracts to improve skin tone
EP2480669A4 (en) Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity
EP2680923A4 (en) Tissue treatment and monitoring by application of energy
MX369616B (en) Skin compositions and methods of use thereof.
ZA201301601B (en) Treatment of diseases
BR212013028314U2 (en) Method to Treat Cancer and Bone Cancer Pain
MX349544B (en) Maesa japonica extracts and methods of use.
EP2613786A4 (en) Treatment of diseases
MX2014001896A (en) Personal care methods.
MX2015003701A (en) Treatment compositions.
GEP201706612B (en) Methods for the treatment of breast cancer
ES2530772T3 (en) Agomelatine Hydrochloride Hydrate and Preparation
HK1255668A1 (en) Composition comprising a diindolylmethane and a retinoid to treat a skin condition
BR112014010294A2 (en) cosmetic composition and method of treatment of a skin condition
PL2785420T3 (en) Cosmetic use of collagen hydrolysate
BR112013023144A2 (en) scalp treatment method
EP2709632A4 (en) Compositions and methods for the treatment of skin diseases
GB201317815D0 (en) Oral supplementation for the reversal of human hair canities
MX2013011694A (en) Taxane and abeo-taxane analogs.
SG11201501719UA (en) Methods to inhibit intracellular growth of bacteria and to treat bacteria-mediated diseases